Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder
Myocyte enhancer factor 2 (MEF2), a family of transcription factor of MADS (minichromosome maintenance 1, agamous, deficiens and serum response factor)-box family needed in the growth and differentiation of a variety of human cells, such as neural, immune, endothelial, and muscles. As per existing l...
Main Authors: | Rishabh Chaudhary, Vipul Agarwal, Arjun Singh Kaushik, Mujeeba Rehman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844021009579 |
Similar Items
-
Genotypes and Phenotypes of MEF2C Haploinsufficiency Syndrome: New Cases and Novel Point Mutations
by: Lin Wan, et al.
Published: (2021-05-01) -
Channelopathy Pathogenesis in Autism Spectrum Disorders
by: Galina eSchmunk, et al.
Published: (2013-11-01) -
Is There Any Association Between the MEF2A Gene Changes and Coronary Artery Disease?
by: Soodeh Omidi, et al.
Published: (2020-11-01) -
Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy
by: Javier Duran, et al.
Published: (2017-09-01) -
Autism spectrum disorders: emerging mechanisms and mechanism-based treatment
by: Hansen eWang, et al.
Published: (2015-05-01)